The purpose of this research is to treat diseases such as arthritis in athletes who are unwilling to receive treatment for artificial joints made of metal and plastic.
Articular cartilage is a weight-bearing connective tissue that covers the ends of bones to prevent friction and protect joints. Cartilage damage can occur due to disease, trauma, and degenerative conditions, such as osteoarthritis, which is one of the main causes of joint pain and inability to move.
More than 300 million people worldwide suffer from osteoarthritis, causing a huge
clinical
And financial burden.Current surgical treatments such as microfractures and
Implants
, Usually only focus on lesion defects and cannot produce durable functional cartilage. Total joint replacement is also the only treatment for advanced osteoarthritis. Implants lack durability over a long period of time, which may lead to bone shortening and other complications.
iPSCs are an alternative cell source and show promise in overcoming these limitations because their self-renewal potential can provide an almost unlimited number of pluripotent cells that can differentiate into many different cell types. Therefore, iPSCs were selected as the basis for scientists to build cartilage structure.
The current tissue engineering technology used for cartilage regeneration can be largely divided into scaffold-based methods and scaffold-free methods.3D printingIt has also been used in many research projects in this field.
For example, scientists from Chalmers University of Technology have previously demonstrated the use of3D bioprintingTechnology to treat osteoarthritis cartilage tissue engineering, microbiologists at Central Queensland University explored crocodile protein and3D bioprintingThe feasibility of a combination of technologies to repair joint damage.Elsewhere, researchers at Penn State University have developed a novel3D printingMethod to create cartilage tissue components with micropores to allow nutrients and oxygen to diffuse.
Japanese scientists’ current research purpose is to use3D bioprintingMachine to design a scaffold-free cartilage structure of anatomical size and shape. The study used Cyfuse biological
medicine
The company’s Regenova Bio-3D printingmachine. Regenova is a new type of robotic system that completes the manufacture of three-dimensional cell structures based on pre-designed three-dimensional data by placing cell spheroids in a fine needle array, the Kenzan method.
More information about this research can be found in the paper titled “Bio-3D printing iPSC-derived human chondrocytes for articularcartilage regeneration” published in the journal Biofabrication. The co-authors of the study are A. Nakamura, D. Murata, R. Fujimoto, S. Tamaki, S. Nagata, M. Ikeya, J. Toguchida, and K. Nakayama.
(Editor in charge: admin)
0 Comments for “Scientists use stem cells to 3D bioprint articular cartilage prostheses, which is expected to improve the treatment of athletes’ joint diseases”